SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Starling Oncology, Inc. backtest

10 trend-following strategies were compared on the full daily history of Starling Oncology, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 93.2%, MDD -46.3%).

Data 2020-06-04 ~ 2026-09-30daily bars 1,589 (6.3 years)Costs 0.5%Venue XNASMonthly snapshot 2026-09-30

Results by strategy

10 of 10 beat buy and hold (CAGR -6.6%, drawdown -98.8%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 93.2%, MDD -46.3%, Sharpe 1.33, 35% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 99.9%p higher than buy and hold, while drawdown improves by 52.5%p (CAGR 93.2%, MDD -46.3%, exposure 35%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=21, threshold=20
93.2%-46.3%1.332.0164.4x3935%
ROC 모멘텀
n=57, threshold=0.14
67.2%-48.9%1.161.3825.8x4029%
SMA 크로스오버
fast=20, slow=84
54.0%-55.3%0.990.9815.3x1940%
볼린저 밴드 돌파
n=58, k=1.7
47.7%-53.4%0.990.8911.7x1929%
EMA 크로스오버
fast=38, slow=48
52.3%-55.3%0.970.9514.3x1542%
Donchian 채널 돌파
entryN=86, exitN=49
45.1%-50.8%0.920.8910.5x931%
MACD
fast=15, slow=22, signal=18
44.4%-86.0%0.860.5210.2x7256%
Keltner 채널 돌파
emaPeriod=41, atrPeriod=10, mult=1.6
37.7%-49.6%0.850.767.6x3330%
Supertrend
period=24, mult=4.9
37.7%-70.2%0.830.547.6x1536%
Parabolic SAR
step=0.015, maxStep=0.16
39.5%-63.0%0.830.638.2x10151%
Buy and hold-6.6%-98.8%0.41-0.070.6x1100%
0.1 1x 10x 2021 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -99% 2021 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -46.3% (2021-12-28 → 2022-05-10), recovered after 527 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 120 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next